3-((2S,4S)-4-Mercapto-1-((4-Nitrobenzyloxy) Carbonyl)-Pyrrolidine-2-Carboxamido Benzoic Acid

Mercaptoproline Orthogonality in Solid-Phase Cyclic Peptide Assembly

The title 4-mercapto-L-proline derivative, bearing a 4-nitrobenzyloxycarbonyl (pNZ) amine protection and a free 3-carboxyanilide terminus, serves as a conformationally constrained cysteine surrogate in medium-scale peptide drug discovery programs. During the linear assembly of a 14-residue bicyclic somatostatin agonist on 2-chlorotrityl chloride resin (1.0–1.4 mmol/g loading), the protected monomer is incorporated at position 6 using a 1.8 eq excess relative to resin substitution. Coupling is mediated by HATU (1.75 eq) and 2,4,6-collidine (3.6 eq) in anhydrous N-methyl-2-pyrrolidone at 18–22°C for 110 min, with single-coupling efficiency exceeding 98.4% as determined by Kaiser test on withdrawn resin aliquots. Residual moisture in the solvent is held below 80 ppm (Karl Fischer titration, ISO 760:1978) to prevent premature cleavage of the acid-labile 2-chlorotrityl anchor. The pNZ group remains fully intact during repetitive 20% piperidine/DMF Fmoc-deprotection cycles, an orthogonality advantage for sequences that contain acid-sensitive side-chain protections or glycosidic bonds. Post-assembly side-chain deprotection and resin cleavage are executed with a cocktail of trifluoroacetic acid/triisopropylsilane/water (95:2.5:2.5 v/v/v) at 25°C for 2.5 h, conditions under which the pNZ mask is quantitatively retained. The crude linear peptide is precipitated in cold tert-butyl methyl ether and purified by reversed-phase flash chromatography (C18, 250 × 50 mm, 10 μm particle size) to a purity of >92% (λ = 220 nm). Cyclization is then performed in solution phase: the peptide is dissolved in 0.1 M ammonium bicarbonate buffer pH 8.2 containing 5 mM EDTA at a concentration of 1.0 mg/mL, and the free mercapto group of the incorporated proline residue is oxidized in air to form a disulfide bridge with a distal cysteine thiol. Stirring under oxygen-enriched headspace (40% O₂) at 30°C for 16–20 h achieves ≥88% intramolecular cyclization with <5% dimer detected by analytical SEC (Superdex Peptide 10/300 GL). Subsequent catalytic transfer hydrogenation using ammonium formate (10 eq) and 10% Pd/C (50% wet, 0.3 g/mmol) in methanol/water (4:1 v/v) at 25°C for 3.5 h removes the pNZ group, liberating the pyrrolidine nitrogen for further functionalization. LC-ESI-MS analysis confirms the final mass within ±0.5 Da of the theoretical monoisotopic value. Operational boundaries are critical: the pNZ deprotection must be performed only after disulfide formation, because premature hydrogenolysis exposes a reducing environment that collapses the disulfide bridge, and the palladium catalyst must be rigorously filtered through a 0.2 μm PTFE membrane to avoid metal contamination exceeding 10 ppm (ICH Q3D elemental impurities guideline). Batch records from kilo-lab campaigns indicate that reaction temperatures above 35°C during the cyclization step promote interchain oligomerization, dropping the monomeric cyclopeptide yield to ≤52%. The finished monomer is lyophilized in Type I glass vials under N₂ backfill and stored at −20°C with a retest period of 24 months per ICH Q1A(R2) stability protocol.

What Drives Selection of the pNZ Group Over Fmoc for ADC Spacer Synthesis?

In the construction of enzyme-responsive cleavable spacers for antibody‑drug conjugates, the simultaneous presence of a nucleophilic thiol, a carboxylic acid, and an amine protection that withstands strong acid but is removed under non‑basic conditions defines a narrow design window. The mercaptoproline derivative is first converted to a heterobifunctional linker core: the 3‑benzoic acid is activated with N‑hydroxysuccinimide (1.2 eq) and N,N′‑dicyclohexylcarbodiimide (1.05 eq) in anhydrous tetrahydrofuran at 0–5°C under argon, affording the NHS ester in 82–88% isolated yield after crystallization from 2‑propanol/n‑heptane (1:3 v/v). The NHS ester is then conjugated to the N‑terminal amine of a valine‑citrulline‑p‑aminobenzyl alcohol peptide segment at pH 7.8 in N,N‑dimethylacetamide/0.1 M HEPES (1:1 v/v), yielding a carboxamide linkage to the benzyl alcohol portion. The free thiol of the proline ring is subsequently reacted with a maleimidocaproyl‑monomethyl auristatin E (mc‑MMAE) payload in citrate buffer pH 6.0 containing 5% (v/v) dimethyl sulfoxide as co‑solvent; a 1.15‑fold molar excess of maleimide over thiol is employed to drive conversion beyond 95% (monitored by Ellman’s assay, DTNB absorbance at 412 nm). The pNZ moiety stays intact through all these transformations — including exposure to the TFA‑labile protecting groups of the peptide spacer — and is only removed in the final step by catalytic transfer hydrogenation with 1,4‑cyclohexadiene (12 eq) and Pearlman’s catalyst (20% Pd(OH)₂/C, 0.15 g/mmol) in ethanol/ethyl acetate (1:2 v/v) at 20°C for 45 min. The liberated pyrrolidine amine can then be converted in situ to a carbamoyl‑based self‑immolative spacer or directly capped with a quencher. A production‑scale batch of 150 g of the linker‑payload conjugate prepared in a 5 L jacketed glass reactor required strict control of the hydrogenation exotherm; jacket inlet temperature was maintained at −5°C during catalyst addition to keep the internal temperature below 25°C, otherwise uncontrolled nitro group reduction generated local hot spots that decomposed the auristatin warhead (loss of potent fragment observed as a +18 Da oxidation peak in LC‑MS). Final purification utilized preparative HPLC on a C8 silica column (100 × 250 mm, 10 μm) with a gradient of 0.1% formic acid in acetonitrile/water, yielding a product of 99.2% chromatographic purity and residual palladium <3 ppm (ICP‑MS, USP <232>). The freeze‑dried solid is stored in amber glass under argon at −25°C; exposure to ambient light for more than 8 h causes photoreduction of the nitro group and gradual loss of the pNZ cap, compromising subsequent bioconjugation stoichiometry. This linker strategy is particularly advantageous when the antibody to be conjugated contains acid‑sensitive inter‑chain disulfides that would be compromised by Boc removal cocktails; the complete absence of HF, TFMSA, or HBr/AcOH in the pNZ cleavage sequence preserves native antibody folding, as confirmed by non‑reducing SDS‑PAGE and size‑exclusion chromatography (TSKgel G3000SWXL, Tosoh) with a monomer purity acceptance criterion of ≥98%.

The deployment of (2S,4S)-configured mercaptoproline building blocks in nanoscale surface engineering bypasses traditional thiol‑methoxy‑poly(ethylene glycol) monolayers where grafting density cannot be tuned independently of terminus reactivity. In a template‑stripped gold sensor chip (RMS roughness <0.5 nm over 1 μm², AFM‑measured per ISO 4287:1997), the compound self‑assembles from a 10 μM solution in ethanol/water (4:1 v/v) over 18 h at 25°C in the dark, forming a saturated monolayer with a thickness of 1.4 ± 0.2 nm (ellipsometry, λ = 632.8 nm, refractive index n = 1.48) and a contact angle of 38° (sessile drop, ASTM D7334-08). The exposed carboxylic acid is subsequently activated with EDC/sulfo‑NHS (200 mM / 50 mM in MES buffer pH 5.5, 7 min reaction) and conjugated to Protein G′ at a surface density of 2.8 ± 0.3 ng/cm² (SPR quantification, Biacore T200). Selective removal of the pNZ cap atop the pyrrolidine ring is achieved by flooding the flow cell with 10 mM sodium dithionite in 0.1 M Tris pH 8.0 for 5 min — a milder alternative to hydrogenolysis compatible with microfluidic chip dimensions — liberating a primary amine for downstream attachment of a fluorescent Alexa Fluor 647 NHS ester. X‑ray photoelectron spectroscopy (take‑off angle 45°, monochromatic Al Kα) of the completely derivatized surface reveals a N 1s peak at 399.8 eV characteristic of amide and amine species, and the absence of the nitro N 1s component at 405.6 eV confirms quantitative deprotection. Spot‑to‑spot reproducibility across a 96‑well SPR chip format shows an intra‑slide CV of <7% for RUmax. Attempts to substitute the pNZ group with an azidomethyl‑based photolabile mask resulted in uncontrolled aggregation during monolayer formation due to head‑group stacking, an incompatibility that underscores the structural utility of the nitrobenzyl carbamate chromophore in suppressing intermolecular π‑π aggregation while providing a stable latent amine handle.

Chromatographic Resin Functionalization and Thiophilic Capture

Agarose‑based chromatographic supports are functionalized with the title compound to create mixed‑mode sorbents that combine weak cation‑exchange capacity via the benzoic acid with metal‑chelating thiophilic character from the deprotected mercapto group. Epichlorohydrin‑activated Sepharose 6 Fast Flow (degree of activation 18–25 μmol epoxy groups/mL settled resin) is suspended in 0.4 M sodium carbonate buffer pH 10.5 containing 10% (v/v) dioxane and reacted with 2.2 eq of the compound relative to epoxy groups at 37°C for 16 h in a shaking incubator. The initial coupling anchors the molecule via the benzoic acid carboxylate under alkaline conditions, while the thiol and amine functionalities remain transiently protected. After washing with deionized water (resistivity ≥ 18.2 MΩ·cm) and 0.1 M sodium acetate pH 4.5, residual epoxy groups are blocked with 1 M ethanolamine pH 9.0 for 4 h. The pNZ group is then removed by passing 5 bed volumes of 0.1 M sodium dithionite in 0.2 M Tris‑HCl pH 8.0 at a linear flow rate of 30 cm/h, a procedure that must be performed with freshly prepared reductant to avoid peroxidized dithionite by‑products that oxidize the liberated thiol. The resulting resin bears a ligand density of 9.6 ± 1.1 μmol/mL bed as determined by elemental sulfur analysis (ASTM D1552-16). When loaded with Ni²⁺ ions via a 50 mM NiSO₄ solution, the stationary phase shows a dynamic binding capacity of 42 mg of hexa‑histidine‑tagged green fluorescent protein per mL resin at 10% breakthrough (linear velocity 150 cm/h, Akta pure 25 system), which represents a 35% increase over the same base matrix functionalized with iminodiacetic acid alone. The chelated Ni²⁺ is stabilized by the thioether‑like coordination of the mercapto group, reducing metal ion leakage to <2 ppm in eluate fractions containing 250 mM imidazole. Column sanitization is performed with 0.5 M NaOH for 30 min contact time; repeated cycling (>60 CIP cycles) revealed no statistically significant loss of capacity or increase in backpressure. The functionalized resin is specified under internal QC #RIN‑OC59 with a certificate of analysis reporting ligand substitution, nickel binding capacity (frontal analysis), and an endotoxin limit of <0.05 EU/mg dry resin (Ph. Eur. 2.6.14) for bioprocessing applications.

In mechanistic enzymology studies addressing serine hydrolase activity, the mercaptoproline derivative is elaborated into a quenched activity‑based probe without isolating the fully deprotected intermediate. The benzoic acid is first conjugated to a sulfo‑cyanine3 fluorophore via a PEG4 diamine spacer under standard PyBOP/DIPEA coupling conditions in DMF (0.1 M, 25°C, 6 h), and the resulting conjugate is purified by flash chromatography on silica gel 60 (ethyl acetate/methanol gradient). The pNZ group is retained during this step and serves as a transient solubility handle. Deprotection with zinc dust (8 eq) and ammonium chloride (10 eq) in methanol/water (3:1 v/v) at 40°C for 90 min — selected over catalytic hydrogenation to avoid dye over‑reduction — generates a free pyrrolidine amine that is immediately trapped with a fluorophosphonate warhead, yielding a covalent inhibitor of prolyl oligopeptidase (POP EC 3.4.21.26). The IC₅₀ of the final probe against recombinant human POP is 7.2 nM (fluorogenic substrate Z‑Gly‑Pro‑AMC, λex 380 nm, λem 460 nm, pH 7.5, 37°C), and labeling of endogenous POP in SH‑SY5Y neuroblastoma lysates is detectable at a probe concentration of 50 nM after 30 min incubation and SDS‑PAGE visualization. Published kinetic data for closely analogous N‑unsubstituted mercaptoproline probes indicate a time‑dependent, two‑step inhibition mechanism with a Ki of approximately 1.8 nM and a k₅ inactivation constant of 0.14 min⁻¹, though explicit figures for the pNZ‑precursor form have not been deposited in public repositories. A critical processing note is that all steps following pNZ removal must be conducted under strictly oxygen‑free conditions (glovebox with <5 ppm O₂) because the liberated thiol‑imine tautomer of the pyrrolidine ring readily undergoes oxidative disulfide homodimerization, a pathway that abolishes active‑site nucleophilic reactivity.